Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - EVNIN LUKE
Last Updated 
13-Aug-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

EVNIN LUKE: Declared Holdings
Company/RelationshipReportedShares  Ownership
Conatus Pharmaceuticals Inc.
Beneficial Owner (10% or more)
NasdaqGM:CNAT
(historical quotes, profile, other insiders)
30-Jul-131,192,080  Indirect
Epizyme, Inc.
Beneficial Owner (10% or more)
NasdaqGS:EPZM
(historical quotes, profile, other insiders)
10-Feb-142,413,819  Indirect
EnteroMedics Inc.
Director
NasdaqCM:ETRM
(historical quotes, profile, other insiders)
8-Jan-141,113,168  Indirect
Pacira Pharmaceuticals, Inc.
Director
NasdaqGS:PCRX
(historical quotes, profile, other insiders)
13-Jun-13
3-Jun-13
0
   824,255
824,255
  Direct
  Indirect  
  Total

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
10-Feb-14 *466,666EPZM Sale at $29.25 per share.
(Proceeds of $13,649,980)
8-Jan-14 *284,531ETRM Sale at $2.50 per share.
(Proceeds of $711,327)
7-Jan-14 *190,334ETRM Sale at $2.50 per share.
(Proceeds of $475,835)
6-Jan-14 *81,720ETRM Sale at $2.50 per share.
(Proceeds of $204,300)
30-Jul-13 *1,026,815CNAT Acquisition (Non Open Market) at $11 per share.
(Value of $11,294,965)
30-Jul-13 *165,265CNAT Purchase at $11 per share.
(Cost of $1,817,915)
13-Jun-13 20,311PCRX Automatic Sale at $30.07 per share.
(Proceeds of $610,751)
12-Jun-13 2,435PCRX Automatic Sale at $30 per share.
(Proceeds of $73,050)
5-Jun-13 *2,702,154EPZM Acquisition (Non Open Market)
3-Jun-13 *82,072PCRX Automatic Sale at $30 per share.
(Proceeds of $2,462,160)
31-May-13 *9,935PCRX Automatic Sale at $30 per share.
(Proceeds of $298,050)
30-May-13 *178,331EPZM Statement of Ownership
30-May-13 *44,582PCRX Automatic Sale at $30 per share.
(Proceeds of $1,337,460)
29-May-13 *20,411PCRX Automatic Sale at $30 per share.
(Proceeds of $612,330)
28-May-13 *195,117PCRX Automatic Sale at $30.62 - $32.14 per share.
(Proceeds of about $6,123,000)
22-May-13 *7,340PCRX Automatic Sale at $30 per share.
(Proceeds of $220,200)
20-May-13 *13,550PCRX Automatic Sale at $30 per share.
(Proceeds of $406,500)
24-Apr-13 *6,303PCRX Automatic Sale at $30.04 per share.
(Proceeds of $189,342)
23-Apr-13 *108,115PCRX Automatic Sale at $30 per share.
(Proceeds of $3,243,450)
15-Apr-13 *2,575PCRX Automatic Sale at $30 per share.
(Proceeds of $77,250)
12-Apr-13 *37,192PCRX Option Exercise at $2.69 per share.
(Cost of $100,046)
12-Apr-13 *3,416PCRX Sale at $29.30 per share.
(Proceeds of $100,088)
12-Apr-13 *10,000PCRX Automatic Sale at $30 per share.
(Proceeds of $300,000)
18-Mar-13 *500,000PCRX Sale at $28.44 per share.
(Proceeds of $14,220,000)
11-Mar-13 *500,000PCRX Sale at $27.86 per share.
(Proceeds of $13,930,000)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?